Activity value 80india Buyer&Supplier,Last transaction date:
2026-07-08
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shilpa pharma lifesciences ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 109 transactions, with a transaction quantity of 53251.4 and a transaction weight of 52584.62.
YearTransactionsQuantityWeight
2025766508553.650219
202610953251.452584.62
Bill of lading data
<
1/15
>
Trade date
2026/07/08
B/L No.
keonnav26mu1480
Suppliers
shilpa pharma lifesciences ltd.
Buyers
vdr de mexico distribucion s a de c v
POLs
53313, jawaharlal nehru
PODs
4601, new york/newark area, newark, nj
Supply area
India
Purchas area
United States
Weight
1889kg
Amount
——
Hs code
294200
Product tags
nifedipine,cod,bulk drug
Product description
HS CODE 29420013 BULK DRUG NIFEDIPINE USP Expand
shilpa pharma lifesciences ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bulk drug,tranexamic acid,ambroxol hcl.
According to the 52wmb.com global trade database, as of 2026-07-08, the company has completed 4241 international trades,
with its main trading regions covering united states,russia,germany etc.
The core products include HS29222190,HS29420090,HS29224990 etc,
often transported via chennai,port hyderabad, port hyderabad air etc,
and its main trading partners are aldrich chemica co,helm de mexico,kuehne nagel roissy cdg.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shilpa pharma lifesciences ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.